Articles from Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026
Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026
Articles from Shaanxi Micot Pharmaceutical Technology Co., Ltd. | MarketMinute